Photodynamic Therapy Based on Graphene and MXene in Cancer Theranostics.
MXene
graphene
nanomedicine
photodynamic therapy
theranostics
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2019
2019
Historique:
received:
14
07
2019
accepted:
09
10
2019
entrez:
12
11
2019
pubmed:
12
11
2019
medline:
12
11
2019
Statut:
epublish
Résumé
Cancer is one of the leading causes of death in the world. Therefore, the development of new advanced and targeted strategies in cancer research for early diagnosis and treatment has become essential to improve diagnosis outcomes and reduce therapy side effects. Graphene and more recently, MXene, are the main representatives of the family of two-dimensional (2D) materials and are widely studied as multimodal nanoplatforms for cancer diagnostics and treatment, in particular leveraging their potentialities as photodynamic therapeutic agents. Indeed, due to their irreplaceable physicochemical properties, they are virtuous allies for photodynamic therapy (PDT) in combination with bioimaging, photothermal therapy, as well as drug and gene delivery. In this review, the rapidly progressing literature related to the use of these promising 2D materials for cancer theranostics is described in detail, highlighting all their possible future advances in PDT.
Identifiants
pubmed: 31709252
doi: 10.3389/fbioe.2019.00295
pmc: PMC6823231
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
295Informations de copyright
Copyright © 2019 Gazzi, Fusco, Khan, Bedognetti, Zavan, Vitale, Yilmazer and Delogu.
Références
ACS Nano. 2018 Nov 27;12(11):10582-10620
pubmed: 30387986
Nature. 2012 Oct 11;490(7419):192-200
pubmed: 23060189
Science. 2005 Jan 28;307(5709):538-44
pubmed: 15681376
Lasers Surg Med. 2006 Jun;38(5):500-8
pubmed: 16634073
Nanoscale. 2014 Jun 21;6(12):6974-83
pubmed: 24835568
Nat Methods. 2008 Sep;5(9):763-75
pubmed: 18756197
Lasers Surg Med. 2013 Aug;45(6):370-6
pubmed: 23775429
Nanoscale. 2013 May 21;5(10):4015-39
pubmed: 23579482
Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11722-11727
pubmed: 30006967
Nat Nanotechnol. 2017 May;12(4):343-350
pubmed: 28135260
J Med Chem. 2004 Jul 29;47(16):3897-915
pubmed: 15267226
Nano Res. 2008;1(3):203-212
pubmed: 20216934
Biomater Sci. 2019 Jun 25;7(7):2729-2739
pubmed: 31017137
J Transl Med. 2014 May 21;12:138
pubmed: 24885781
Mater Sci Eng C Mater Biol Appl. 2016 Apr 1;61:953-64
pubmed: 26838925
Nat Rev Cancer. 2003 May;3(5):380-7
pubmed: 12724736
ACS Appl Mater Interfaces. 2014 Jul 23;6(14):11173-9
pubmed: 24979179
Adv Healthc Mater. 2016 Sep;5(17):2283-94
pubmed: 27385651
Cancer Res. 2004 Mar 15;64(6):2120-6
pubmed: 15026352
Chem Commun (Camb). 2019 May 9;55(39):5540-5546
pubmed: 31033990
Theranostics. 2011 Apr 13;1:240-50
pubmed: 21562631
Acc Chem Res. 2013 Jan 15;46(1):138-48
pubmed: 22872046
Nano Converg. 2016;3(1):4
pubmed: 28191414
Int J Mol Sci. 2018 Nov 12;19(11):null
pubmed: 30424535
Mater Sci Eng C Mater Biol Appl. 2017 Aug 1;77:1363-1375
pubmed: 28532014
Science. 2016 Sep 9;353(6304):1137-40
pubmed: 27609888
Adv Drug Deliv Rev. 2019 Jan 1;138:211-232
pubmed: 30172925
Technol Cancer Res Treat. 2005 Jun;4(3):283-93
pubmed: 15896084
Nanoscale. 2015 Feb 14;7(6):2520-6
pubmed: 25573051
Adv Healthc Mater. 2016 Jan 21;5(2):276-87
pubmed: 26687729
Expert Opin Drug Deliv. 2016;13(1):155-65
pubmed: 26559178
Int J Mol Sci. 2015 Aug 31;16(9):20523-59
pubmed: 26334268
Nat Commun. 2017 Oct 24;8(1):1109
pubmed: 29061960
ACS Nano. 2011 Sep 27;5(9):7000-9
pubmed: 21815655
Theranostics. 2018 Feb 8;8(6):1648-1664
pubmed: 29556347
Theranostics. 2014 Jan 15;4(3):229-39
pubmed: 24505232
Br J Cancer. 2004 Aug 2;91(3):441-6
pubmed: 15238981
Biomaterials. 2014 May;35(15):4499-507
pubmed: 24602568
Nanoscale. 2018 Jul 5;10(25):11820-11830
pubmed: 29920573
Nano Lett. 2008 Dec;8(12):4373-9
pubmed: 19367969
J Phys Chem C Nanomater Interfaces. 2014 May 15;118(19):10519-10529
pubmed: 24860637
Biomater Sci. 2017 May 2;5(5):901-952
pubmed: 28401206
Acta Biomater. 2017 Apr 15;53:631-642
pubmed: 28161572
Small. 2013 Aug 26;9(16):2721-9, 2720
pubmed: 23447468
Trends Biotechnol. 2018 Nov;36(11):1145-1156
pubmed: 29954613
Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):255-274
pubmed: 27037064
Chem Commun (Camb). 2013 Feb 11;49(12):1202-4
pubmed: 23283113
Adv Healthc Mater. 2018 May;7(9):e1701394
pubmed: 29405649
Nat Protoc. 2017 Feb;12(2):355-371
pubmed: 28102836
J Photochem Photobiol B. 2014 Jun 5;135:7-16
pubmed: 24792568
Nat Nanotechnol. 2018 Jul;13(7):537-543
pubmed: 29980781
Anal Chem. 2017 Apr 4;89(7):4077-4084
pubmed: 28281746
Clin Endosc. 2013 Jan;46(1):7-23
pubmed: 23423543
Expert Opin Drug Deliv. 2008 Nov;5(11):1241-54
pubmed: 18976134
Nano Lett. 2017 Jan 11;17(1):384-391
pubmed: 28026960
Nanoscale. 2018 Jan 18;10(3):1180-1188
pubmed: 29271441
Biomaterials. 2016 Jul;95:1-10
pubmed: 27108401
Adv Drug Deliv Rev. 2013 Dec;65(15):2087-97
pubmed: 23751779
Biomaterials. 2013 Aug;34(26):6239-48
pubmed: 23706688
Nanophotonics. 2017 Aug;6(5):853-879
pubmed: 29226063
Angew Chem Int Ed Engl. 2017 Mar 6;56(11):3014-3019
pubmed: 28156035
Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):228-241
pubmed: 27233212
Nanomedicine (Lond). 2014 Jul;9(10):1475-86
pubmed: 25253496
Adv Mater. 2011 Oct 4;23(37):4248-53
pubmed: 21861270
Nanoscale. 2018 Jul 5;10(25):11719-11731
pubmed: 29917035
ACS Appl Mater Interfaces. 2016 Jul 13;8(27):17176-86
pubmed: 27320692
J Am Chem Soc. 2017 Nov 15;139(45):16235-16247
pubmed: 29063760
Theranostics. 2015 Mar 28;5(7):710-23
pubmed: 25897336
Nat Protoc. 2013 Dec;8(12):2392-403
pubmed: 24202553
ACS Nano. 2018 Oct 23;12(10):10419-10429
pubmed: 30207690
Nat Commun. 2014 Aug 08;5:4596
pubmed: 25105845
Bioorg Med Chem Lett. 2014 Apr 1;24(7):1638-49
pubmed: 24594351
Adv Sci (Weinh). 2018 Jul 19;5(10):1800518
pubmed: 30356929
Adv Mater. 2013 Apr 24;25(16):2258-68
pubmed: 23494834
Theranostics. 2016 Feb 13;6(4):485-500
pubmed: 26941842
Biomaterials. 2013 Oct;34(31):7715-24
pubmed: 23859660
CA Cancer J Clin. 2011 Jul-Aug;61(4):250-81
pubmed: 21617154
Nature. 2014 Dec 4;516(7529):78-81
pubmed: 25470044
Biomaterials. 2015 Feb;42:94-102
pubmed: 25542797
Small. 2015 Jun 3;11(21):2527-35
pubmed: 25626859
ACS Nano. 2017 Dec 26;11(12):12696-12712
pubmed: 29156126
Nat Nanotechnol. 2009 Apr;4(4):217-24
pubmed: 19350030
Nat Nanotechnol. 2018 Sep;13(9):777-785
pubmed: 30190620
Dalton Trans. 2018 Mar 12;47(11):3931-3939
pubmed: 29459928
Nat Biotechnol. 2004 Aug;22(8):969-76
pubmed: 15258594
Acc Chem Res. 2013 Oct 15;46(10):2307-18
pubmed: 23276286
J Am Chem Soc. 2015 Sep 9;137(35):11376-82
pubmed: 26284535
Chem Soc Rev. 2015 May 7;44(9):2681-701
pubmed: 25519856
Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):163-175
pubmed: 27235665
Nanomedicine (Lond). 2016 Feb;11(3):269-87
pubmed: 26787429
Nat Nanotechnol. 2019 Jul;14(7):629-635
pubmed: 31270452
ACS Nano. 2017 Oct 24;11(10):9574-9593
pubmed: 28933820
ACS Appl Mater Interfaces. 2017 Nov 22;9(46):40077-40086
pubmed: 29099168
Pharmaceutics. 2018 Dec 16;10(4):null
pubmed: 30558378